Pubblicazioni rilevanti su riviste internazionali indicizzate a primo ed ultimo nome

Altre Pubblicazioni

Hepatic-specific Pgc-1α ablation drives fibrosis in a MASH model
Liver International • Luglio/2024
Hepatic-specific Pgc-1α ablation drives fibrosis in a MASH model
Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
Cell & Bioscience • Giugno/2024
Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men
Biology of Sex Differences • Maggio/2024
Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men
Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients
Internal and Emergency Medicine • Aprile/2024
Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients
Gut microbiota in the pathogenesis and therapeutic
EBIOMEDICINE • Ottobre/2023
Gut microbiota in the pathogenesis and therapeutic
Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
JHEP REPORTS • Novembre/2022
Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
JOURNAL OF HEPATOLOGY • Agosto/2021
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
Cell Mol Gastroenterol Hepatol • Febbraio/2021
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
EBIOMEDICINE • Aprile/2020
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
Hepatic Peroxisome Proliferator-Activated Receptor c Coactivator 1b Drives Mitochondrial and Anabolic Signatures That Contribute to Hepatocellular Carcinoma Progression in Mice
HEPATOLOGY • Marzo/2018
Hepatic Peroxisome Proliferator-Activated Receptor c Coactivator 1b Drives Mitochondrial and Anabolic Signatures That Contribute to Hepatocellular Carcinoma Progression in Mice
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
CELL METABOLISM • Aprile/2015
Uncoupling Nuclear Receptor LXR and Cholesterol Metabolism in Cancer
Prevention of Spontaneous Hepatocarcinogenesis in Farnesoid X Receptor–Null Mice by Intestinal-Specific Farnesoid X Receptor Reactivation
HEPATOLOGY • Gennaio/2015
Prevention of Spontaneous Hepatocarcinogenesis in Farnesoid X Receptor–Null Mice by Intestinal-Specific Farnesoid X Receptor Reactivation
Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
CELL REPORTS • Aprile/2014
Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
Neuron-Derived Orphan Receptor 1 Promotes Proliferation of Quiescent Hepatocytes
GASTROENTEROLOGY • Giugno/2013
Neuron-Derived Orphan Receptor 1 Promotes Proliferation of Quiescent Hepatocytes
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice
GASTROENTEROLOGY • Giugno/2013
Liver X receptors inhibit proliferation of human colorectal cancer cells and growth of intestinal tumors in mice
Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor c Coactivator-1b Protects Against Steatohepatitis
HEPATOLOGY • Aprile/2013
Hepatic-Specific Activation of Peroxisome Proliferator-Activated Receptor c Coactivator-1b Protects Against Steatohepatitis
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver
HEPATOLOGY • Dicembre/2012
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver